(19)
(11)
EP 0 935 654 A1
(12)
(43)
Date of publication:
18.08.1999
Bulletin 1999/33
(21)
Application number:
97916166.0
(22)
Date of filing:
21.03.1997
(51)
International Patent Classification (IPC):
C12N
15/
02
( . )
A61K
31/
70
( . )
A61K
35/
76
( . )
A61K
49/
00
( . )
A61P
25/
00
( . )
A61P
35/
00
( . )
C07K
16/
22
( . )
C12N
1/
19
( . )
C12N
5/
10
( . )
C12N
15/
12
( . )
C12P
21/
08
( . )
A61K
31/
00
( . )
A61K
31/
7088
( . )
A61K
48/
00
( . )
A61K
51/
00
( . )
A61P
25/
02
( . )
C07K
14/
50
( . )
C12N
1/
15
( . )
C12N
1/
21
( . )
C12N
15/
09
( . )
C12P
21/
02
( . )
A61K
38/
00
( . )
(86)
International application number:
PCT/US1997/004641
(87)
International publication number:
WO 1997/035007
(
25.09.1997
Gazette 1997/41)
(84)
Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
(30)
Priority:
21.03.1996
US 19960621143
(71)
Applicant:
THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Baltimore, MD 21205 (US)
(72)
Inventors:
NATHANS, Jeremy
Baltimore, MD 21209 (US)
SMALLWOOD, Philip, M.
Woodbine, MD 21797-9621 (US)
TONG, Patrick
Baltimore, MD 21210-1522 (US)
(74)
Representative:
VOSSIUS & PARTNER
Siebertstrasse 4
81675 München
81675 München (DE)
(54)
FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTOR-3 (FHF-3) AND METHODS OF USE